FDA extends comment time on rule for US imports:
This article was originally published in Clinica
Executive Summary
The FDA has reopened the comment period for a further 60 days on its proposed rule requiring foreign establishments whose food, drug and device products are imported into the US to register with the FDA. The Canadian government said the proposed requirement could present significant cost and compliance burdens to its small and medium-sized companies so it needed more time to prepare comments and ensure that its firms are aware of the proposal. The comment period initially ended on July 28 it will now close on October 8.